Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a collaboration to advance new prostate ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new ...

October 9, 2026.I finished my consultation with Dr. Ken Kumagai at the Fukushima Urology Clinic.This was to confirm the results of the blood test I took last week.PSA value, 0.59.PSA is a blood test ...

Find out when it’s worth seeing a doctor about.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

A qualitative study of 28 cancer survivors and 19 health professionals finds that information about chronic bowel symptoms ...

In the 1960s, Sir John Charnley, CBE, FRS, posited that periprosthetic joint infection was one of the most difficult ...

The Zakia Al Mu'een Foundation organised a Free Comprehensive Health Check-Up Camp at the Sri Lanka High Commission, bringing together allopathic screening, preventive diagnostics, and traditional ...

Occasionally, Sivado savors a victory. Before heading home, she stopped under a downtown overpass to see James Myers, 66, who ...

Androgen deprivation therapy (ADT) can be an effective treatment for men diagnosed with prostate cancer. By blocking testosterone, the therapy can slow or stop the cancer, contributing to a disease ...

Not long ago, Georgia gubernatorial nominee Rick Jackson eagerly compared himself to his fellow billionaire in the Oval ...

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.